Caplin Point Laboratories Limited (BOM:524742)
India · Delayed Price · Currency is INR 2,835.80
-30.00 (-1.05%)
At close: Sep 25, 2026
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 215.55 billion as of September 25, 2026. Its market cap has increased by 25.36% in one year.
Market Cap
215.55B
Enterprise Value
206.72B
Revenue
22.87B
Ranking
n/a
PE Ratio
32.49
Stock Price
2,835.80
ChartMarket Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 215.55B, an increase of 3,849,765.47%. That is a compound annual growth rate of 53.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 215.55B | 54.02% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 571.86B |
| GlaxoSmithKline Pharmaceuticals | 477.19B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 211.49B |
| Jubilant Pharmova | 168.44B |
| AstraZeneca Pharma India | 162.95B |
| Viyash Scientific | 107.39B |
| Procter & Gamble Health | 90.03B |